Full
Outline
To analyze the disease burden of lung cancer attributable to high fasting plasma glucose (HFPG) in China from 1990 to 2021 and its trends, and to predict the disease burden trends from 2022 to 2036, providing evidence for targeted prevention and control measures.
Using the Global Burden of Disease (GBD) 2021 data, Joinpoint regression was employed to analyze the trends in age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life years (DALYs) rate (ASDR) of lung cancer attributable to HFPG in China. An age-period-cohort (APC) model was used to assess age, period, and cohort effects, and R software was utilized to predict future disease burden trends.
From 1990 to 2021, the ASMR and ASDR of lung cancer attributable to HFPG in China showed an overall upward trend, with average annual percentage changes (AAPCs) of 1.28% and 1.05%, respectively (both P<0.001). The disease burden was generally higher in males than in females. With increasing age, it showed a trend of initial increase followed by a decrease, with the highest increase in mortality and DALY rates observed in the 80-84 age group. The net drift values for mortality and DALYs rate in the APC model were 0.90% (95% CI: 0.69%-1.11%) and 0.89% (95% CI: 0.69%-1.08%), respectively. The age effect indicated that mortality peaked in the 90-94 age group, while DALYs rate peaked in the 75-79 age group. The period effect showed that mortality and DALYs risks initially increased and then decreased over time. The cohort effect revealed an overall upward trend in mortality and DALYs risks with successive birth cohorts. It was projected that by 2036, the ASMR of lung cancer attributable to HFPG in China may decline to 0.74 and 0.50 per 100 000 for males and females, respectively, while the ASDR may decrease to 18.59 and 10.62 per 100 000.
From 1990 to 2021, the disease burden of lung cancer attributable to HFPG in China exhibits an overall upward trend, with higher burdens observed in males and older adults. Greater attention should be paid to middle-aged and elderly male populations, and more targeted prevention and intervention policies should be implemented.
29
15
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
